| Virulence factors of uropathogenic Escherichia coli L Emody, M Kerenyi, G Nagy International journal of antimicrobial agents 22, 29-33, 2003 | 331 | 2003 |
| tRNA genes and pathogenicity islands: influence on virulence and metabolic properties of uropathogenic Escherichia coli A Ritter, G Blum, L Emödy, M Kerenyi, A Böck, B Neuhieri, W Rabsch, ... Molecular microbiology 17 (1), 109-121, 1995 | 130 | 1995 |
| Influence of RecA onin vivovirulence and Shiga toxin 2 production inEscherichia colipathogens S Fuchs, I Mühldorfer, A Donohue-Rolfe, M Kerényi, L Emödy, R Alexiev, ... Microbial pathogenesis 27 (1), 13-23, 1999 | 109 | 1999 |
| Occurrence of hlyA and sheA Genes in Extraintestinal Escherichia coli Strains M Kerényi, HE Allison, I Bátai, A Sonnevend, L Emödy, N Plaveczky, ... Journal of clinical microbiology 43 (6), 2965-2968, 2005 | 67 | 2005 |
| The impact of drugs used in anaesthesia on bacteria I Batai, M Kerenyi, M Tekeres European journal of anaesthesiology 16 (7), 425-440, 1999 | 65 | 1999 |
| Bacterial growth in ropivacaine hydrochloride I Bátai, M Kerényi, J Falvai, G Szabó Anesthesia & Analgesia 94 (3), 729-731, 2002 | 64 | 2002 |
| Characterization of Asymptomatic Bacteriuria Escherichia coli Isolates in Search of Alternative Strains for Efficient Bacterial Interference against Uropathogens C Stork, B Kovács, B Rózsai, J Putze, M Kiel, Á Dorn, J Kovács, S Melegh, ... Frontiers in microbiology 9, 214, 2018 | 37 | 2018 |
| Tazarotene induces epidermal cell differentiation in the mouse tail test used as an animal model for psoriasis B Sebök, B Bonnekoh, M Kerényi, H Gollnick Skin Pharmacology and Physiology 13 (5), 285-291, 2000 | 37 | 2000 |
| Lidocaine/prilocaine cream (EMLA®) has an antibacterial effect in vitro M Kerenyi, R Batai, V Juhasz, I Batai Journal of Hospital Infection 56 (1), 75-76, 2004 | 32 | 2004 |
| A state-of-the-art guide to the sterilization of thermoplastic polymers and resin materials used in the additive manufacturing of medical devices R Told, Z Ujfalusi, A Pentek, M Kerenyi, K Banfai, A Vizi, P Szabo, ... Materials & design 223, 111119, 2022 | 23 | 2022 |
| A comparison of the antimicrobial property of lidocaine/prilocaine cream (EMLA®) and an alcohol-based disinfectant on intact human skin flora I Batai, L Bogar, V Juhasz, R Batai, M Kerenyi Anesthesia & Analgesia 108 (2), 666-668, 2009 | 22 | 2009 |
| The growth of bacteria in intravenous glyceryl trinitrate and in sodium nitroprusside I Bátai, M Kerényi, M Tekeres Anesthesia & Analgesia 89 (6), 1570, 1999 | 18 | 1999 |
| Re-evaluation of in vitro activity of primycin against prevalent multiresistant bacteria P Feiszt, G Mestyán, M Kerényi, O Dobay, J Szabó, Z Dombrádi, E Urbán, ... International Journal of Medical Microbiology 304 (8), 1077-1085, 2014 | 17 | 2014 |
| Enhancement of the antiparakeratotic potency of calcitriol and tacalcitol in liposomal preparations in the mouse tail test JN Körbel, B Sebök, M Kerenyi, G Mahrle Skin Pharmacology and Physiology 14 (5), 291-295, 2001 | 17 | 2001 |
| Effect of fumaric acid, its dimethylester, and topical antipsoriatic drugs on epidermal differentiation in the mouse tail model B Sebök, T Szabados, M Kerényi, I Schneider, G Mahrle Skin Pharmacology and Physiology 9 (2), 99-103, 1996 | 16 | 1996 |
| A modified bioautographic method for antibacterial component screening against anaerobic and microaerophilic bacteria JK Kovács, G Horváth, M Kerényi, B Kocsis, L Emődy, G Schneider Journal of microbiological methods 123, 13-17, 2016 | 15 | 2016 |
| Impact of medications on bacterial growth in syringes M Kerenyi, Z Borza, C Csontos, B Ittzes, I Batai Journal of Hospital Infection 79 (3), 265-266, 2011 | 14 | 2011 |
| Anti-Escherichia coli alpha-haemolysin in control and patient sera. L Emödy, I Batai Jr, M Kerényi, J Szekely Jr, L Polyak Anti-Escherichia coli alpha-haemolysin in control and patient sera. 2, 1982 | 14 | 1982 |
| Histological and antimicrobial study of Ononis arvensis L. T Dénes, SG Bartha, M Kerényi, E Varga, VL Balázs, R Csepregi, N Papp Acta Biologica Hungarica 68 (3), 321-333, 2017 | 13 | 2017 |
| Effects of pituitary adenylate cyclase activating polypeptide on small intestinal INT 407 cells A Illés, B Opper, D Reglodi, M Kerényi, P Czetany, A Boronkai, E Schafer, ... Neuropeptides 65, 106-113, 2017 | 12 | 2017 |
Heather E. AllisonInstitute of Integrative Biology, University of LiverpoolVerified email at liverpool.ac.uk
